Research map: Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission

Back to the article

Papers in this map

  1. Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection · Chloe M. Orkin · 2020 · 500 citations · Cited by this paper
  2. Comparative Effectiveness of Teicoplanin Versus Standard of Care Antibiotics for the Treatment of Gram-Positive Bacteremia: A Seven-Year Retrospective Analysis · 2026 · Related
  3. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011 · Claire L Townsend · 2014 · 399 citations · Cited by this paper
  4. Evaluation of Quantitative Differences of Classic Methods, Fungal Biomarkers, and T2Candida for Assessing the Central Venous Catheter Origin of Candidemia · 2026 · Related
  5. No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception · Laurent Mandelbrot · 2015 · 313 citations · Cited by this paper
  6. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in the 20-Valent Pneumococcal Conjugate Vaccine in the Adult Population in France · 2026 · Related
  7. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis · Ravindra K. Gupta · 2009 · 257 citations · Cited by this paper
  8. Thiazolidinedione use and risk of bacterial enteric infection among adults with type 2 diabetes mellitus · 2026 · Related
  9. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis · Steve Kanters · 2020 · 139 citations · Cited by this paper
  10. Identification of Contacts With High Rates of Missed and Asymptomatic Infection Following an Outbreak of Ebola Virus Disease: A Seroepidemiological Study in Likati Health Zone, Democratic Republic of the Congo · 2026 · Related
  11. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis · Tom Loosli · 2023 · 137 citations · Cited by this paper
  12. Seasonally Varying Effects of Improved Water, Sanitation, and Handwashing Interventions on Giardia Infection in Bangladesh · 2026 · Related
  13. Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis · Frédérique Chammartin · 2018 · 110 citations · Cited by this paper
  14. Delays in Tuberculosis Treatment Among People With Pulmonary Tuberculosis in East Africa: Findings From a Prospective Cohort Study · 2026 · Related
  15. The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis · Andrew N. Phillips · 2021 · 79 citations · Cited by this paper
  16. Human Exposure to Spirochete-Infected Ornithodoros turicata in a Residential Setting in the Austin, Texas Metropolitan Area · 2026 · Related
  17. Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models · Nigel Campbell Rollins · 2012 · 74 citations · Cited by this paper
  18. Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat’AIDS Cohort) · 2026 · Related
  19. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study · Jienchi Dorward · 2023 · 73 citations · Cited by this paper
  20. Direct-Acting Antiviral Therapy and Long-Term Outcomes in Dialysis Patients With Hepatitis C: A Real-world Cohort Study · 2026 · Related
  21. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential · Caitlin M. Dugdale · 2019 · 70 citations · Cited by this paper
  22. Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead – a systematic review · Minh Duc Pham · 2022 · 64 citations · Cited by this paper
  23. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review · Carolyn Chu · 2024 · 59 citations · Cited by this paper
  24. SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial · John Kinuthia · 2021 · 54 citations · Cited by this paper
  25. Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial · Monica Gandhi · 2024 · 45 citations · Cited by this paper
  26. Will drug resistance against dolutegravir in initial therapy ever occur? · Mark A. Wainberg · 2015 · 42 citations · Cited by this paper
  27. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States · Kunjal Patel · 2022 · 35 citations · Cited by this paper
  28. Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya · Appolonia Aoko · 2023 · 30 citations · Cited by this paper
  29. The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at Failure · Helen Bell‐Gorrod · 2020 · 29 citations · Cited by this paper
  30. Retention in care and viral suppression in the PMTCT continuum at a large referral facility in western Kenya · John M. Humphrey · 2022 · 25 citations · Cited by this paper
  31. Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings · Caitlin M. Dugdale · 2023 · 22 citations · Cited by this paper
  32. Retention and viral suppression of newly diagnosed and known HIV positive pregnant women on Option B+ in Western Kenya · Eliud Akama · 2018 · 21 citations · Cited by this paper
  33. What prevents pregnant women from adhering to the continuum of maternal care? Evidence on interrelated mechanisms from a cohort study in Kenya · Nursena Aksünger · 2022 · 19 citations · Cited by this paper
  34. Differences in Breastfeeding Duration by Maternal HIV Status: A Pooled Analysis of Nationally Representative Surveys in Sub-Saharan Africa · Robert L. Glaubius · 2024 · 16 citations · Cited by this paper
  35. Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges · Katerina A. Christopoulos · 2024 · 14 citations · Cited by this paper
  36. Efficacy of long‐acting cabotegravir plus rilpivirine in viraemic people living with HIV : A systematic review and meta‐analysis · Beatrice Barda · 2025 · 9 citations · Cited by this paper
  37. Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa · Andrew N. Phillips · 2025 · 9 citations · Cited by this paper
  38. Near-point-of-care viral load testing during pregnancy and viremia at delivery · Jessica Joseph · 2022 · 7 citations · Cited by this paper
  39. Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study · Andrew N. Phillips · 2025 · 7 citations · Cited by this paper

Source: OpenAlex (CC0)